STHL Seksuaalsel teel levivate infektsioonide ravijuhis Eestis 2007

42
Kirjandus
1. Gall SA. Human Papillomavirus. Infectious Diseases in Women. Ed.: Faro S, Soper DE, W. B.
Saunders Company 2001; 468–483.
2. Munoz N, Franceschi S et al. Role of parity and human papillomavirus in cervical cancer: the
IARC multicentic case-control study. LANCET 2002; 359: 1093.
3. Wilkinson EJ, Xie Dong-Lin. Benign Diseases of the Vulva. Blausteins Pathology of the Fe
male Genital Tract. Ed.: Kurman RJ. Springer-Verlag 2002; 37.
4. Stentella, P; Frega, A; Ciccarone, M, et al. HPV and intraepithelial neoplasia recurrent lesions
of the lower genital tract: assessment of the immune system. EUR J GYNAECOL ONCOL
1998; 19 (5): 466.
5. Wright TC, Ferency A. Benign Diseases of the Cervix. Blausteins Pathology of the Female
Genital Tract. Ed.: Kurman RJ, Springer-Verlag, 2002; 225–256.
6. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guide
lines 2006. MMWR 2006; 55(No. RR-11): pp 69-78.
7. Centers for Disease Control and Prevention. Quadrivalent Human Papillomavirus Vaccine.
MMWR Early Release 2007; 56(March 12): pp 1-19.
8. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent
Cervical Cancer and its Precursors. CA Cancer J Clin 2007;57;7-28.